期刊名称:PATIENT PREFERENCE AND ADHERENCE
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
An international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal.
Journal Impact Factor: 1.333
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
Instructions to Authors
Preparation of Manuscript
Include:
- Forename(s) and surnames of authors (see Authorship section below)
- Author affiliations: department, institution, city, state, country
- Abstract 300 words
- 3–6 keywords
- Running header (shortened title)
- Corresponding author: name, physical address, phone, fax, email
- Double-spacing
- 3-cm margins
- Page numbers
- Clear concise language
- American spelling
- Ensure tables and figures are cited
- The preferred electronic format for text is Microsoft Word
- Manuscripts will be accepted in LaTeX as long as the native LaTeX and a PDF is also supplied
- Use International Systems of Units (SI) symbols and recognized abbreviations for units of measurement
- Do not punctuate abbreviations eg, et al, ie
- Spell out acronyms in the first instance in the abstract and paper
- Word counts are not specified. In general, shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500
- Generic drug names are used in text, tables, and figures
- Suppliers of drugs, equipment, and other brand-name material are credited in parentheses (company, name, city, state, country)
- If molecular sequences are used, provide a statement that the data have been deposited in a publicly accessible database, eg, GenBank, and indicate the database accession number.
While the editors fully understand the extra challenges posed to authors whose native language is not English, we must ask that all manuscripts be reviewed and edited by a native speaker of English with expertise in that area prior to submission.
Authorship
Authorship credit should be based on: 1) Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) Drafting the article or revising it critically for important intellectual content; 3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript (3). These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. The NLM indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript; it also lists the names of collaborators if they are listed in Acknowledgments.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
All persons designated as authors should qualify for authorship, and all those who qualify should be listed.
Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship/contributorship.
The group should jointly make decisions about contributors/authors before submitting the manuscript for publication. The corresponding author/guarantor should be prepared to explain the presence and order of these individuals. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship.
Contributors Listed in Acknowledgments
All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chairperson who provided only general support. Authors should declare whether they had assistance with study design, data collection, data analysis, or manuscript preparation. If such assistance was available, the authors should disclose the identity of the individuals who provided this assistance and the entity that supported it in the published article. Financial and material support should also be acknowledged.
Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under such headings as “clinical investigators” or “participating investigators,” and their function or contribution should be described—for example, “served as scientific advisors,” “critically reviewed the study proposal,” “collected data,” or “provided and cared for study patients.” Because readers may infer their endorsement of the data and conclusions, these persons must give written permission to be acknowledged.
Please note: the Authorship and “Contributors Listed in Acknowledgments” sections are reprinted from the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Dove Medical Press prepared this reprint. The ICMJE has not endorsed nor approved the contents of this reprint. The official version of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals is located at www.ICMJE.org. Users should cite this official version when citing the document. Related Authors
Where authors of a paper are related this should be disclosed at the time of submission. Please provide details of the family relationship between such authors.
Figures and Tables
- Submit as one file
- Number consecutively
- Provide a descriptive heading/legend
- Place abbreviations immediately below the table
- Use superscript a, b, c… as identifiers
- Submit figures as PDF or JPG files
- Supply Line Art 900 dpi, Combination (Line Art + Halftone) 900 dpi, Halftone 300 dpi
- Graphics downloaded from Web pages are NOT acceptable
- Submit multi-panel figures, ie with parts labeled a,b,c,d, as one file
Supplementary Data
Any supplementary data should be kept to 6 typeset pages or 2,400 words. If you have any more than this you should provide a link to the supplementary data on an external website, your institute’s website for example, and/or Dove Medical Press may be able to upload the raw supplementary data to the http://www.dovepress.com/ website and provide a link in your paper. We welcome video files either as supplementary data or as part of the actual manuscript to show operations, procedures, etc.
Letter to the Editor
Manuscripts submitted as a Letter to the Editor:
- Should relate to a paper previously published in a Dove Medical Press journal, or address an issue of wider concern within the scope of the journal;
- Have a word count of no more than 3,600 words;
- May contain figures and tables (see specifications for these above);
- Have references formatted in the Dove Medical Press style.
Submission of Manuscript
- All manuscripts should be submitted via our website.
- By doing so you agree to the terms and conditions of submission
- Keep a backup and hard copies of the material submitted
Pre-submissions
- Authors are welcome to send an abstract or draft manuscript to obtain a view from the Editor about the suitability of their paper. Please email here and include which journal you are interested in submitting your manuscript to. Our Editors will do a quick review (not peer review) of your paper and advise if they believe it is appropriate for submission to their journal. This will be based on subject matter vs the aims and scope of the journal. It will not be a full review of your manuscript.
Reference Style
See Reference Style Guidelines
Proofs
- You will receive the typeset page proofs for approval
- Check amendments made by the editor have not rendered the material inaccurate
- Check you have answered all the editor’s queries
- Ensure your corrections are minimal and absolutely necessary
- Mark the adjustments clearly in the text and margins, and keep a copy of what you send to the editor
- Notify the editorial office of all corrections within 72 hours of your receipt of the material
- Ensure all authors sign and return the Author Approval and final page of Publication Agreement
Editorial Board
A
Dr Atlas
Integrated Blood Pressure Control
B
Dr Binetruy
Stem Cells and Cloning: Advances and Applications
Dr Bluth
Journal of Biorepository Science for Applied Medicine
Dr Bluth
Pharmacogenomics and Personalized Medicine
C
Dr Chen
Patient Preference and Adherence
Dr Chen
Neuroscience and Neuroeconomics
Dr Colli
Research and Reports in Urology
D
Dr Davis
International Journal of Interferon, Cytokine and Mediator Research
E
Dr Elman
Psychology Research and Behavior Management
F
G
Dr Gayed
Research and Reports in Nuclear Medicine
H
K
Dr Kieran
Clinical Oncology in Adolescents and Young Adults
Dr Kones
Research Reports in Clinical Cardiology
L
Dr Lai
HIV/AIDS - Research and Palliative Care
Dr Lane
Research and Reports in Biodiversity Studies
Dr Li
Research and Reports in Medicinal Chemistry
M
Dr Murthy
Research and Reports in Transdermal Drug Delivery
Dr Musser
Veterinary Medicine: Research and Reports
O
Dr O'Reilly
Gastrointestinal Cancer: Targets and Therapy
Dr Okunseri
Clinical, Cosmetic and Investigational Dentistry
Dr Onel
Cancer Management and Research
P
Dr Pape
Open Access Emergency Medicine
Dr Perujo
Energy and Emission Control Technologies
Dr Pilch
Drug Design, Development and Therapy
Dr Pinder
International Journal of Wine Research
Dr Pinder
Neuropsychiatric Disease and Treatment
Dr Price
Pragmatic and Observational Research
Q
R
S
Dr Shea
Nature and Science of Sleep
T
Dr Todd
Integrated Pharmacy Research and Practice
U
V
Dr Voils
Comparative Effectiveness Research
W
Dr Wahls
International Journal of High Throughput Screening
Dr Walsh
Therapeutics and Clinical Risk Management
Dr Wang
Antibody Technology Journal
Dr Weinberg
Clinical, Cosmetic and Investigational Dermatology
Dr Wirz
Local and Regional Anesthesia
Dr Wu
Substance Abuse and Rehabilitation
Dr Wu
Open Access Medical Statistics
X
Dr Xing
Research and Reports in Endocrine Disorders
Y
Z
Dr Zhang
Pathology and Laboratory Medicine International
Professor Zou
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
|